Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Prignano

Showing results (1-10 of 193) with videos related to

Pageof 20
Sort By:
The British Journal of Dermatology|June 18, 2024
Comment on 'Morphology: the mother of all biomarkers'Francesca Prignano, Elia Rosi
Dermatology (Basel, Switzerland)|May 10, 2022
Looking at Interleukin-22 from a New Dermatological Perspective: From Epidermal Homeostasis to Its Role in Chronic Skin DiseasesFrancesca Prignano, Elena Donetti
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 25, 2012
Gottron papules: a pathognomonic sign of dermatomyositisFederica Ricceri, Francesca Prignano
Experimental Dermatology|September 28, 2023
12th European Hidradenitis Suppurativa (EHSF) e.V. Conference-Facing HS according to the Renessaince styleChristos C Zouboulis, Francesca Prignano
The Journal of Rheumatology. Supplement|May 3, 2014
Restarting biologics and management of patients with flares of inflammatory rheumatic disorders or psoriasis during active tuberculosis treatmentFabrizio Cantini, Francesca Prignano, Delia Goletti
The Journal of Dermatological Treatment|May 21, 2020
Is biologic treatment of hidradenitis suppurativa during the COVID-19 pandemic different from psoriasis biologic treatment?Elia Rosi, Nicola Pimpinelli, Francesca Prignano
Dermatologic Clinics|July 31, 2007
New and experimental treatments of vitiligo and other hypomelanosesTorello Lotti, Francesca Prignano, Gionata Buggiani
The Journal of Rheumatology. Supplement|May 3, 2014
Tuberculosis reactivation risk in dermatologyLeonardo Pescitelli, Federica Ricceri, Francesca Prignano
Expert Opinion on Biological Therapy|June 21, 2022
Place in therapy of anti-IL-17 and 23 in psoriasis according to the severity of comorbidities: a focus on cardiovascular disease and metabolic syndromeEmanuele Trovato, Pietro Rubegni, Francesca Prignano
European Journal of Dermatology : EJD|April 30, 2002
Acute leucocytoclastic vasculitis and aquagenic pruritus long preceding polycythemia rubra veraGianni Gerlini, Francesca Prignano, Nicola Pimpinelli
Pageof 20

Showing results (1-10 of 193) with videos related to

Sort By:
Pageof 20
The British Journal of Dermatology|June 18, 2024
Comment on 'Morphology: the mother of all biomarkers'Francesca Prignano, Elia Rosi
Dermatology (Basel, Switzerland)|May 10, 2022
Looking at Interleukin-22 from a New Dermatological Perspective: From Epidermal Homeostasis to Its Role in Chronic Skin DiseasesFrancesca Prignano, Elena Donetti
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 25, 2012
Gottron papules: a pathognomonic sign of dermatomyositisFederica Ricceri, Francesca Prignano
Experimental Dermatology|September 28, 2023
12th European Hidradenitis Suppurativa (EHSF) e.V. Conference-Facing HS according to the Renessaince styleChristos C Zouboulis, Francesca Prignano
The Journal of Rheumatology. Supplement|May 3, 2014
Restarting biologics and management of patients with flares of inflammatory rheumatic disorders or psoriasis during active tuberculosis treatmentFabrizio Cantini, Francesca Prignano, Delia Goletti
The Journal of Dermatological Treatment|May 21, 2020
Is biologic treatment of hidradenitis suppurativa during the COVID-19 pandemic different from psoriasis biologic treatment?Elia Rosi, Nicola Pimpinelli, Francesca Prignano
Dermatologic Clinics|July 31, 2007
New and experimental treatments of vitiligo and other hypomelanosesTorello Lotti, Francesca Prignano, Gionata Buggiani
The Journal of Rheumatology. Supplement|May 3, 2014
Tuberculosis reactivation risk in dermatologyLeonardo Pescitelli, Federica Ricceri, Francesca Prignano
Expert Opinion on Biological Therapy|June 21, 2022
Place in therapy of anti-IL-17 and 23 in psoriasis according to the severity of comorbidities: a focus on cardiovascular disease and metabolic syndromeEmanuele Trovato, Pietro Rubegni, Francesca Prignano
European Journal of Dermatology : EJD|April 30, 2002
Acute leucocytoclastic vasculitis and aquagenic pruritus long preceding polycythemia rubra veraGianni Gerlini, Francesca Prignano, Nicola Pimpinelli
Pageof 20